Korean Market
MATR
Alteogen
★

Alteogen Free Stock Issuance Listing Date Revised: Minor Administrative Correction, No Impact on Terms or Shareholder Value

 
EXCH
Alteogen
★

Alteogen Sets Record Date of August 6, 2026 for Free Stock Issuance Shareholder Determination

 
EXCH
Alteogen
★

Alteogen Trading Suspension for Free Stock Issuance, Dilution Expected from Share Increase

 
MATR
Alteogen
★

Alteogen Declares 30% Stock Dividend, Shares Increase to 69 Million, No Dilution of Shareholder Value

 
EXCH
Alteogen
★

Alteogen temporarily suspends transfer listing to KOSPI, opts to maintain KOSDAQ listing

 
EXCH
Alteogen
★

Alteogen to Hold IR Event at 2026 BofA Korea Conference with Limited Direct Impact on Shareholder Value

 
PERI
Alteogen
★★★★

Alteogen reports 1Q26 consolidated revenue KRW71.6bn, operating profit KRW39.3bn; strong global licensing deals

 
EXCH
Alteogen
★★★★★

EYZANFY (ALT-L9, Aflibercept Biosimilar) Receives MFDS Marketing Approval

 
EXCH
Alteogen
★

Alteogen 2026 Q1 Provisional Earnings: Sales -14.5% YoY, Operating Profit +100% QoQ